Raffi Kapitanyan, MD
Emergency Medical Services · New Brunswick, NJNPI 1245269083
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by AstraZeneca at 51.9% of the total.
Across 39 payments — averaging $11.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$242
- Aytu Biopharma, Inc.$170
- Genentech USA, Inc.$40
- GSK$14
What the payments were for
- Food & beverage$467100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $242 |
| Aytu Biopharma, Inc. | 21 | $170 |
| Genentech USA, Inc. | 3 | $40 |
| GSK | 1 | $14 |
How this compares
$467 in reported general payments places this provider in the 85th percentile of 21 emergency medical services providers in New Jersey.
See all emergency medical services providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CefuroximeCefuroxime Axetil | 66 | $683 |
| Methylprednisolone | 112 | $611 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 88 | $562 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $544 |
| Cephalexin | 25 | $291 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 34 | $286 |
| Prednisone | 67 | $152 |
| Triamcinolone Acetonide | 15 | $144 |
| Ciprofloxacin Hcl | 28 | $122 |
| Doxycycline Hyclate | 17 | $114 |
| Azithromycin | 24 | $90 |
| Fluconazole | 14 | $45 |
| Levofloxacin | 11 | $43 |
Paid to pharmacies, not to this prescriber.
Other emergency medical services in New Brunswick
- Andreia Marques-BaptistaNew Brunswick$422
- Steven HochmanPaterson$814
- Ninad ShroffPaterson$670
- Randi KillianPlainsboro$645
- Jamil RizqallaLivingston$356
- Joseph FeldmanHackensack$348
- John AdamsMorristown$268
- Daniel MerzAtlantic City$219
- Garrett TomasinoAtlantic City$189
- Cosimo LaterzaMorristown$173
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.